{"id":308,"date":"2015-01-23T12:29:49","date_gmt":"2015-01-23T14:29:49","guid":{"rendered":"http:\/\/www.planetaw.com.br\/temp\/sbg\/?p=308"},"modified":"2019-06-24T15:49:05","modified_gmt":"2019-06-24T18:49:05","slug":"relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual","status":"publish","type":"post","link":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/","title":{"rendered":"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL"},"content":{"rendered":"<div class=\"span12\"><span class=\"tituloDoutorEsq\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-677 size-full\" src=\"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2015\/01\/Luciana-Malta-de-Alencar.jpg\" alt=\"\" width=\"100\" height=\"120\" \/><strong>Editor Associado e Comentarios por Luciana Alencar sobre:<\/strong><br \/>\nRef.:<strong> Point-wise relationships between visual field sensitivity and macular thickness determined by<br \/>\nspectral-domain optical coherence tomography.<\/strong><br \/>\nKim JM, Sung KR, Yoo YC, Kim CY.<br \/>\n<strong>Curr Eye Res. 2013 Aug;38(8):894-901.<\/strong><br \/>\n<\/span><\/div>\n<p>H\u00e1 muitos anos, diversos pesquisadores t\u00eam investigado o potencial benef\u00edcio da avalia\u00e7\u00e3o macular com OCT no diagn\u00f3stico e acompanhamento do paciente com glaucoma. Essa linha de pesquisa tomou novo f\u00f4lego com o lan\u00e7amento dos novos aparelhos de OCT espectral. <span class=\"destaqueBgAzul\">Essa \u00e9 uma \u00e1rea de interesse pois a maioria das c\u00e9lulas ganglionares da retina encontra-se na regi\u00e3o macular, ao menos um ter\u00e7o da espessura macular \u00e9 representada justamente por essas c\u00e9lulas, e a variabilidade interindividual nesta regi\u00e3o \u00e9 menor do que no restante da retina.<\/span><\/p>\n<p><span class=\"destaqueBgVerdeFloat\">&#8220;por\u00e9m, ainda n\u00e3o est\u00e1 claro o benef\u00edcio adicional que a avalia\u00e7\u00e3o macular tem na avalia\u00e7\u00e3o cl\u00ednica do paciente com glaucoma quando comparado a avalia\u00e7\u00e3o camada fibras peripapilar.&#8221;<\/span>O estudo de Kim et. al incluiu 106 pacientes com glaucoma (definido como presen\u00e7a de defeito de campo visual correlacionada com neuropatia \u00f3ptica glaucomatosa), e o objetivo foi comparar a sensibilidade dos pontos centrais da campimetria 24-2 com a m\u00e9dia da espessura de \u00e1reas correspondentes no mapa de assimetria macular do OCT Spectralis. Os resultados demostraram associa\u00e7\u00f5es estatisticamente significantes entre os setores comparados, sugerindo um potencial uso da avalia\u00e7\u00e3o macular pelo OCT no acompanhamento de pacientes com glaucoma.<\/p>\n<p>No entanto, embora seja estatisticamente significante, a associa\u00e7\u00e3o observada foi fraca em grande parte. A an\u00e1lise mostrou que apenas uma pequena parte da variabilidade na sensibilidade do campo visual pode ser explicada por altera\u00e7\u00f5es na espessura da retina macular. Essa associa\u00e7\u00e3o est\u00e1 de acordo com a observada com outros aparelhos de OCT, por\u00e9m, ainda n\u00e3o est\u00e1 claro o benef\u00edcio adicional que a avalia\u00e7\u00e3o macular tem na avalia\u00e7\u00e3o cl\u00ednica do paciente com glaucoma quando comparado a avalia\u00e7\u00e3o camada fibras peripapilar.<\/p>\n<div class=\"envolveConteudo\">\n<div class=\"accordion-noticias\">\n<h3 style=\"background-color: #dadada;\"><img decoding=\"async\" src=\"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2015\/03\/seg.png\" \/>Resumo deste artigo<\/h3>\n<div>\n<div class=\"accordion-resumo\">\n<div class=\"box-isolado\">\n<p><em>Curr Eye Res<\/em>. 2013 Aug;38(8):894-901. doi: 10.3109\/02713683.2013.787433. Epub 2013 Apr 17.<br \/>\n<em>Point-wise relationships between visual field sensitivity and macular thickness determined by spectral-domain optical coherence tomography<\/em>.<br \/>\nKim JM, Sung KR, Yoo YC, Kim CY.<br \/>\n<strong>Author information<\/strong><\/p>\n<p><strong>Abstract<\/strong><\/p>\n<p><strong>PURPOSE<\/strong>:<br \/>\nTo evaluate the point-wise relationships between visual field sensitivity (VFS), as measured by standard automated perimetry (SAP), and macular thickness, as determined by spectral-domain optical coherence tomography (SD-OCT), in patients with glaucoma.<\/p>\n<p><strong>MATERIALS AND METHODS<\/strong>:<br \/>\nOne hundred and six glaucoma subjects (one eye per subject) recruited from an academic institution underwent SAP tests (Humphrey field analyzer, central 24-2 of Swedish Interactive Thresholding Algorithm standard) and SD-OCT volume scans (SPECTRALIS, posterior pole asymmetry analysis). The retinal sensitivities of 16 central test points from the SAP results were recorded. Macular thickness values from 4 square cells in an 8\u2009\u00d7\u20098 posterior pole retinal thickness map were averaged for a mean retinal thickness (MRT) value, which corresponded to the 16 central test points in the SAP. In each 16-point area, linear regression analyses of the VFS and the MRT value were performed.<\/p>\n<p><strong>RESULTS<\/strong>:<br \/>\nThe VFS of each 16 central test point showed a significant relationship with the corresponding MRT values (R(2)=\u20090.133-0.383, all p\u2009&lt;\u20090.001). Central and nasal test points corresponding to an arcuate region revealed a relatively strong correlation in both the superior and inferior hemispheres (R(2)=\u20090.311-0.383 and 0.288-0.345, respectively), but the superior and inferior-temporal points revealed a relatively weaker correlation (R(2)=\u20090.149 and 0.133, respectively).<\/p>\n<p><strong>CONCLUSIONS<\/strong>:<br \/>\nThe VFS showed a significant reciprocal relationship with corresponding macular thickness at each test point. However, the level of the relationship varied among different macular sectors, showing the strongest relationship in the arcuate region.<\/p>\n<p>PMID: 23594170 [PubMed &#8211; in process]<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Editor Associado e Comentarios por Luciana Alencar sobre: Ref.: Point-wise relationships between visual field sensitivity and macular thickness determined by spectral-domain optical coherence tomography. Kim JM, Sung KR, Yoo YC, Kim CY. Curr Eye Res. 2013 Aug;38(8):894-901. H\u00e1 muitos anos, diversos pesquisadores t\u00eam investigado o potencial benef\u00edcio da avalia\u00e7\u00e3o macular com OCT no diagn\u00f3stico e [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_joinchat":[],"footnotes":""},"categories":[1],"tags":[],"class_list":["post-308","post","type-post","status-publish","format-standard","hentry","category-sem-categoria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL - SBG - Sociedade Brasileira de Glaucoma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL - SBG - Sociedade Brasileira de Glaucoma\" \/>\n<meta property=\"og:description\" content=\"Editor Associado e Comentarios por Luciana Alencar sobre: Ref.: Point-wise relationships between visual field sensitivity and macular thickness determined by spectral-domain optical coherence tomography. Kim JM, Sung KR, Yoo YC, Kim CY. Curr Eye Res. 2013 Aug;38(8):894-901. H\u00e1 muitos anos, diversos pesquisadores t\u00eam investigado o potencial benef\u00edcio da avalia\u00e7\u00e3o macular com OCT no diagn\u00f3stico e [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/\" \/>\n<meta property=\"og:site_name\" content=\"SBG - Sociedade Brasileira de Glaucoma\" \/>\n<meta property=\"article:published_time\" content=\"2015-01-23T14:29:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-06-24T18:49:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbglaucoma2.websiteseguro.com\/medico\/wp-content\/uploads\/2015\/01\/Luciana-Malta-de-Alencar.jpg\" \/>\n<meta name=\"author\" content=\"Ricardo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ricardo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/\"},\"author\":{\"name\":\"Ricardo\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#\\\/schema\\\/person\\\/3b5653b1267e6a6d05de21f0ebd8e3c2\"},\"headline\":\"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL\",\"datePublished\":\"2015-01-23T14:29:49+00:00\",\"dateModified\":\"2019-06-24T18:49:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/\"},\"wordCount\":619,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2015\\\/01\\\/Luciana-Malta-de-Alencar.jpg\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/\",\"url\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/\",\"name\":\"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL - SBG - Sociedade Brasileira de Glaucoma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2015\\\/01\\\/Luciana-Malta-de-Alencar.jpg\",\"datePublished\":\"2015-01-23T14:29:49+00:00\",\"dateModified\":\"2019-06-24T18:49:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#\\\/schema\\\/person\\\/3b5653b1267e6a6d05de21f0ebd8e3c2\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2015\\\/01\\\/Luciana-Malta-de-Alencar.jpg\",\"contentUrl\":\"https:\\\/\\\/sbglaucoma.org.br\\\/medico\\\/wp-content\\\/uploads\\\/2015\\\/01\\\/Luciana-Malta-de-Alencar.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#website\",\"url\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/\",\"name\":\"SBG - Sociedade Brasileira de Glaucoma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/#\\\/schema\\\/person\\\/3b5653b1267e6a6d05de21f0ebd8e3c2\",\"name\":\"Ricardo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g\",\"caption\":\"Ricardo\"},\"url\":\"https:\\\/\\\/www.sbglaucoma.org.br\\\/medico\\\/author\\\/ricardo\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL - SBG - Sociedade Brasileira de Glaucoma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/","og_locale":"pt_BR","og_type":"article","og_title":"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL - SBG - Sociedade Brasileira de Glaucoma","og_description":"Editor Associado e Comentarios por Luciana Alencar sobre: Ref.: Point-wise relationships between visual field sensitivity and macular thickness determined by spectral-domain optical coherence tomography. Kim JM, Sung KR, Yoo YC, Kim CY. Curr Eye Res. 2013 Aug;38(8):894-901. H\u00e1 muitos anos, diversos pesquisadores t\u00eam investigado o potencial benef\u00edcio da avalia\u00e7\u00e3o macular com OCT no diagn\u00f3stico e [&hellip;]","og_url":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/","og_site_name":"SBG - Sociedade Brasileira de Glaucoma","article_published_time":"2015-01-23T14:29:49+00:00","article_modified_time":"2019-06-24T18:49:05+00:00","og_image":[{"url":"https:\/\/sbglaucoma2.websiteseguro.com\/medico\/wp-content\/uploads\/2015\/01\/Luciana-Malta-de-Alencar.jpg","type":"","width":"","height":""}],"author":"Ricardo","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Ricardo","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#article","isPartOf":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/"},"author":{"name":"Ricardo","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#\/schema\/person\/3b5653b1267e6a6d05de21f0ebd8e3c2"},"headline":"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL","datePublished":"2015-01-23T14:29:49+00:00","dateModified":"2019-06-24T18:49:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/"},"wordCount":619,"commentCount":0,"image":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#primaryimage"},"thumbnailUrl":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2015\/01\/Luciana-Malta-de-Alencar.jpg","inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/","url":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/","name":"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL - SBG - Sociedade Brasileira de Glaucoma","isPartOf":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#primaryimage"},"image":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#primaryimage"},"thumbnailUrl":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2015\/01\/Luciana-Malta-de-Alencar.jpg","datePublished":"2015-01-23T14:29:49+00:00","dateModified":"2019-06-24T18:49:05+00:00","author":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#\/schema\/person\/3b5653b1267e6a6d05de21f0ebd8e3c2"},"breadcrumb":{"@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#primaryimage","url":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2015\/01\/Luciana-Malta-de-Alencar.jpg","contentUrl":"https:\/\/sbglaucoma.org.br\/medico\/wp-content\/uploads\/2015\/01\/Luciana-Malta-de-Alencar.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/relacao-espessura-macular-avaliada-pelo-oct-vs-campo-visual\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.sbglaucoma.org.br\/medico\/"},{"@type":"ListItem","position":2,"name":"RELA\u00c7\u00c3O ESPESSURA MACULAR AVALIADA PELO OCT VS. CAMPO VISUAL"}]},{"@type":"WebSite","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#website","url":"https:\/\/www.sbglaucoma.org.br\/medico\/","name":"SBG - Sociedade Brasileira de Glaucoma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sbglaucoma.org.br\/medico\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/www.sbglaucoma.org.br\/medico\/#\/schema\/person\/3b5653b1267e6a6d05de21f0ebd8e3c2","name":"Ricardo","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44920876e908c0295955ee29232efe54c5c4ae3c36c5fc42ce7d3fba63ad79e4?s=96&d=mm&r=g","caption":"Ricardo"},"url":"https:\/\/www.sbglaucoma.org.br\/medico\/author\/ricardo\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts\/308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/comments?post=308"}],"version-history":[{"count":7,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts\/308\/revisions"}],"predecessor-version":[{"id":6253,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/posts\/308\/revisions\/6253"}],"wp:attachment":[{"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/media?parent=308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/categories?post=308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sbglaucoma.org.br\/medico\/wp-json\/wp\/v2\/tags?post=308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}